Im vergangenen Jahr erzielte Phibro Animal Health Corp für sein leistungsstärkstes Segment, MFAs and Other, Einnahmen von 810.73M USD. Die Region United States leistete den größten Beitrag mit 877.13M USD im letzten Jahr. Im letzten Quartal berichtete Phibro Animal Health Corp über Einnahmen in Höhe von 207.63M USD für den Zeitraum bis zum 2026-06-30, die aus dem leistungsstärksten Segment, MFAs and Other, stammten. United States trug mit 220.25M USD den höchsten Umsatz bei.

Nach Geschäftsbereich

Umsatz

Anteil

Jährlich

Jährlich

Vierteljährlich

MFAs and Other

Nutritional specialties

Vaccines

FY2026

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

MFAs and Other

810.73M(69.76%)

646.35M(67.13%)

420.96M(59.59%)

387.35M(58.70%)

361.54M(59.56%)

330.02M(60.47%)

322.30M(61.17%)

350.47M(65.88%)

Nutritional specialties

195.07M(16.78%)

179.29M(18.62%)

164.67M(23.31%)

172.50M(26.14%)

157.20M(25.89%)

142.76M(26.16%)

129.26M(24.53%)

113.22M(21.28%)

Vaccines

156.42M(13.46%)

137.15M(14.25%)

120.85M(17.11%)

100.00M(15.15%)

88.32M(14.55%)

72.94M(13.37%)

75.34M(14.30%)

68.29M(12.84%)

Nach Region

Umsatz

Anteil

Jährlich

Jährlich

Vierteljährlich

United States

Europe & Middle East & Africa

Asia Pacific

Latin America and Canada

Israel

FY2026

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

United States

877.13M(57.78%)

739.92M(57.08%)

584.76M(57.46%)

578.77M(59.19%)

561.80M(59.62%)

494.89M(59.39%)

471.94M(58.97%)

480.10M(57.98%)

494.60M(60.32%)

484.15M(63.35%)

473.25M(62.97%)

475.94M(63.58%)

435.41M(62.93%)

414.77M(63.50%)

424.37M(64.88%)

Europe & Middle East & Africa

340.67M(22.44%)

160.23M(12.36%)

121.98M(11.99%)

117.81M(12.05%)

122.48M(13.00%)

114.13M(13.70%)

112.18M(14.02%)

105.36M(12.73%)

43.90M(5.35%)

40.21M(5.26%)

36.18M(4.81%)

36.40M(4.86%)

38.56M(5.57%)

32.50M(4.98%)

30.09M(4.60%)

Asia Pacific

187.94M(12.38%)

97.42M(7.52%)

63.23M(6.21%)

61.45M(6.28%)

66.93M(7.10%)

58.01M(6.96%)

57.30M(7.16%)

90.15M(10.89%)

51.41M(6.27%)

50.48M(6.61%)

46.44M(6.18%)

43.22M(5.77%)

43.42M(6.28%)

44.06M(6.75%)

36.93M(5.65%)

Latin America and Canada

112.36M(7.40%)

298.65M(23.04%)

247.71M(24.34%)

219.85M(22.48%)

191.05M(20.28%)

166.32M(19.96%)

158.94M(19.86%)

152.38M(18.40%)

120.85M(14.74%)

96.69M(12.65%)

105.67M(14.06%)

99.58M(13.30%)

84.78M(12.25%)

68.58M(10.50%)

61.41M(9.39%)

Israel

--(--)

109.22M(13.32%)

92.75M(12.14%)

90.00M(11.98%)

93.46M(12.48%)

89.74M(12.97%)

93.25M(14.28%)

101.30M(15.49%)